Are you looking for clinical trials related to Alzheimer's prevention in Hawaii? If so, you're in luck! Hawaii Pacific Neuroscience was one of the centers that participated in clinical trials of the drug Leqembi for people with early-stage Alzheimer's disease.
Leqembi
is the first drug that has been shown to slow memory loss. Clinical trials are research studies that involve people. The main goal is to find a better way to prevent, diagnose and treat a disease.These studies are part of a long and careful research process. Patients participating in a clinical trial receive drugs or procedures that have already been investigated in successful laboratory or animal studies. Most clinical trials investigate new drugs or procedures. The company said that in a phase 3 clinical trial, the drug, called lecanemab, reduced cognitive decline by 27% after 18 months. The results were announced in a press release and have not yet been peer-reviewed. The proven model of the Hawaii Pacific Neuroscience Clinical Research Center (CRC) and the combined years of experience allow Hawaiian patients to access new and innovative neuroscientific treatment options.
The Hawaii Pacific Health Research Institute (HPHRI) is dedicated to supporting clinical trials within the Hawaii Pacific Health network of hospitals: Kapiolani, Pali Momi, Straub and Wilcox. If you're interested in participating in a clinical trial related to prevention and Alzheimer's in Hawaii, you should contact your doctor or the Hawaii Pacific Health Research Institute for more information. They can provide you with more details about the available clinical trials and help you decide if it's right for you.
